TOCANCIPÁ, Colombia, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) ("Clever Leaves" or the "Company"), a global medicinal cannabis company, announced that it received notice from The Nasdaq Stock Market LLC ("Nasdaq") on September 11, 2023 informing the Company that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) (the "Rule") for continued listing on the Nasdaq Capital Market.
On September 29, 2022, Clever Leaves received notice from Nasdaq that the Company was not in compliance with the Rule, as its common shares failed to meet a closing bid price of $1.00 or more for 30 consecutive business days. Clever Leaves received an additional 180 calendar day period to regain compliance on March 29, 2023, and the Company conducted a 1-for-30 reverse split of its common shares with marketplace effectiveness on August 25, 2023 to aid the compliance process.
To regain compliance with the Rule, the Company's common shares were required to maintain a minimum closing bid price of $1.00 or more for at least 10 consecutive business days. This requirement was met on September 8, 2023.
About Clever Leaves Holdings Inc.
Clever Leaves is a global medical cannabis company. Its operations in Colombia produce EU GMP cannabinoid active pharmaceutical ingredients (API) and finished products in flower and extract form to a growing base of B2B customers around the globe. Clever Leaves aims to disrupt the traditional cannabis production industry by leveraging environmentally sustainable, ESG-friendly, industrial-scale and low-cost production methods, with the world's most stringent pharmaceutical quality certifications. Clever Leaves announces material information to the public through a variety of means, including filings with the Securities and Exchange Commission (the "SEC"), press releases, public conference calls, and its website ( Clever Leaves uses these channels, as well as social media, including its Twitter account (@clever_leaves), and its LinkedIn page ( to communicate with investors and the public about Clever Leaves, its products, and other matters. Therefore, Clever Leaves encourages investors, the media, and others interested in Clever Leaves to review the information it makes public in these locations, as such information could be deemed to be material information. Information on or that can be accessed through Clever Leaves' websites or these social media channels is not part of this release, and references to Clever Leaves' website addresses and social media channels are inactive textual references only.
Clever Leaves Investor Inquiries:
Cody Slach or Jackie Keshner
Gateway Group, Inc.
+1-949-574-3860
CLVR@Gateway-grp.com
Clever Leaves Press Contact:
Maria Petsanas
KCSA Strategic Communications
+1-917-692-6673
cleverleaves@kcsa.com
Clever Leaves Commercial Inquiries:
Andrew Miller
Head of Global Business Development
+1-416-817-1336
andrew.miller@cleverleaves.com
哥倫比亞託坎西帕,2023年9月13日(GLOBE NEWSWIRE)——全球藥用大麻公司Clever Leaves Holdings Inc.(納斯達克股票代碼:CLVR、CLVRW)(“Clever Leaves” 或 “公司”)宣佈,它已於2023年9月11日收到納斯達克股票市場有限責任公司(“納斯達克”)的通知,通知該公司已重新遵守納斯達克上市規則第55條下的最低出價要求 50 (a) (2)(“規則”),用於繼續在納斯達克資本市場上市。
2022年9月29日,Clever Leaves收到納斯達克的通知,稱該公司沒有遵守該規則,因爲其普通股連續30個工作日未能達到1.00美元或以上的收盤價。2023年3月29日,Clever Leaves又獲得了180個日曆日的期限,以恢復合規性,該公司於2023年8月25日對普通股進行了1比30的反向拆分,具有市場效力,以幫助合規流程。
爲了重新遵守該規則,該公司的普通股必須至少連續10個工作日將最低收盤價維持在1.00美元或以上。該要求已於 2023 年 9 月 8 日得到滿足。
關於 Clever Leaves 控股公司
Clever Leaves是一家全球性的醫用大麻公司。其在哥倫比亞的業務爲全球不斷增長的B2B客戶羣生產歐盟GMP大麻素活性藥物成分(API)和花卉和提取物形式的成品。Clever Leaves旨在通過利用環境可持續、ESG友好、工業規模和低成本的生產方法以及世界上最嚴格的藥品質量認證來顛覆傳統的大麻生產行業。Clever Leaves通過各種方式向公衆公佈重要信息,包括向美國證券交易委員會(“SEC”)提交文件、新聞稿、公開電話會議及其網站(Clever Leaves使用這些渠道以及社交媒體,包括其Twitter賬戶(@clever_leaves)和LinkedIn頁面(與投資者和公衆就Clever Leaves及其產品和其他事項進行溝通)。因此,Clever Leaves鼓勵投資者、媒體和其他對Clever Leaves感興趣的人查看其在這些地方公開的信息,因爲此類信息可能被視爲重要信息。有關或可以通過Clever Leaves網站或這些社交媒體渠道訪問的信息不屬於本新聞稿的一部分,對Clever Leaves網站地址和社交媒體渠道的引用僅爲非活躍的文字引用。
Clever 離開了投資者的詢問:
Cody Slach 或 Jackie Keshner
蓋特威集團有限公司
+1-949-574-3860
CLVR@Gateway-grp.com
Clever Leaves 媒體聯繫人
瑪麗亞·佩薩納斯
KCSA 戰略傳播
+1-917-692-6673
cleverleaves@kcsa.com
Clever 留下了商業調查:
安德魯·米勒
全球業務發展主管
+1-416-817-1336
andrew.miller@cleverleaves.com